Andreas Laner

1.3k total citations
33 papers, 495 citations indexed

About

Andreas Laner is a scholar working on Pathology and Forensic Medicine, Molecular Biology and Genetics. According to data from OpenAlex, Andreas Laner has authored 33 papers receiving a total of 495 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pathology and Forensic Medicine, 14 papers in Molecular Biology and 10 papers in Genetics. Recurrent topics in Andreas Laner's work include Genetic factors in colorectal cancer (17 papers), Cancer Genomics and Diagnostics (9 papers) and Genomics and Rare Diseases (7 papers). Andreas Laner is often cited by papers focused on Genetic factors in colorectal cancer (17 papers), Cancer Genomics and Diagnostics (9 papers) and Genomics and Rare Diseases (7 papers). Andreas Laner collaborates with scholars based in Germany, United States and Netherlands. Andreas Laner's co-authors include Elke Holinski‐Feder, Monika Morak, Gisela Keller, Heather Hampel, Anna Benet‐Pagès, Barbara Heidenreich, Albert de la Chapelle, Hans Scheffer, Nicole de Leeuw and Ulrike Bacher and has published in prestigious journals such as International Journal of Cancer, Journal of Medical Genetics and Pediatric Research.

In The Last Decade

Andreas Laner

30 papers receiving 488 citations

Peers

Andreas Laner
Keiyan Sy Canada
Linka Xie China
Hongming Qiu United States
Sally E. Trabucco United States
Joseph Washburn United States
Andreas Laner
Citations per year, relative to Andreas Laner Andreas Laner (= 1×) peers Bryony A. Thompson

Countries citing papers authored by Andreas Laner

Since Specialization
Citations

This map shows the geographic impact of Andreas Laner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Laner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Laner more than expected).

Fields of papers citing papers by Andreas Laner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas Laner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Laner. The network helps show where Andreas Laner may publish in the future.

Co-authorship network of co-authors of Andreas Laner

This figure shows the co-authorship network connecting the top 25 collaborators of Andreas Laner. A scholar is included among the top collaborators of Andreas Laner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreas Laner. Andreas Laner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lucas, Morghan C., T. Keßler, Verena Steinke‐Lange, et al.. (2025). A series of reviews in familial cancer: genetic cancer risk in context variants of uncertain significance in MMR genes: which procedures should be followed?. Familial Cancer. 24(2). 42–42. 1 indexed citations
2.
Marina, Adela Della, Andreas Hentschel, Ulrike Schara‐Schmidt, et al.. (2024). Novel Genetic and Biochemical Insights into the Spectrum of NEFL -Associated Phenotypes. Journal of Neuromuscular Diseases. 11(3). 625–645. 3 indexed citations
3.
Steinke‐Lange, Verena, et al.. (2023). Transcript capture and ultradeep long-read RNA sequencing (CAPLRseq) to diagnose HNPCC/Lynch syndrome. Journal of Medical Genetics. 60(8). 747–759. 10 indexed citations
4.
Laner, Andreas, Philipp Arnold, Eileen Socher, et al.. (2023). Novel Homozygous FA2H Variant Causing the Full Spectrum of Fatty Acid Hydroxylase-Associated Neurodegeneration (SPG35). Genes. 15(1). 14–14. 5 indexed citations
5.
Henkel, Jan, Andreas Laner, Kerstin Becker, et al.. (2023). Diagnostic yield and clinical relevance of expanded germline genetic testing for nearly 7000 suspected HBOC patients. European Journal of Human Genetics. 31(8). 925–930. 6 indexed citations
6.
Neuhann, Teresa, et al.. (2022). Long-term chemoprevention in patients with adenomatous polyposis coli: an observational study. Familial Cancer. 21(4). 463–472. 6 indexed citations
7.
Neuhann, Teresa, Verena Steinke‐Lange, Andreas Laner, et al.. (2022). Highly sensitive liquid biopsy Duplex sequencing complements tissue biopsy to enhance detection of clinically relevant genetic variants. Frontiers in Oncology. 12. 1014592–1014592. 5 indexed citations
8.
Morak, Monika, Marta Pineda, Alexandra Martins, et al.. (2022). Splicing analyses for variants in MMR genes: best practice recommendations from the European Mismatch Repair Working Group. European Journal of Human Genetics. 30(9). 1051–1059. 5 indexed citations
9.
Morak, Monika, Alex Hastie, Andreas Laner, et al.. (2021). Constitutional chromothripsis of the APC locus as a cause of genetic predisposition to colon cancer. Journal of Medical Genetics. 59(10). 976–983. 12 indexed citations
10.
Diebold, Isabel, et al.. (2020). Critical assessment of secondary findings in genes linked to primary arrhythmia syndromes. Human Mutation. 41(5). 1025–1032. 8 indexed citations
12.
Morak, Monika, Verena Steinke‐Lange, Anna Benet‐Pagès, et al.. (2020). Prevalence of CNV-neutral structural genomic rearrangements in MLH1, MSH2, and PMS2 not detectable in routine NGS diagnostics. Familial Cancer. 19(2). 161–167. 9 indexed citations
13.
Morak, Monika, et al.. (2019). Targeted deep-intronic sequencing in a cohort of unexplained cases of suspected Lynch syndrome. European Journal of Human Genetics. 28(5). 597–608. 11 indexed citations
14.
Koehler, Udo, et al.. (2018). Extending the critical regions for mutations in the non‐coding gene RNU4ATAC in another patient with Roifman Syndrome. Clinical Case Reports. 6(11). 2224–2228. 7 indexed citations
15.
Spier, Isabel, Martin Kerick, Dmitriy Drichel, et al.. (2016). Exome sequencing identifies potential novel candidate genes in patients with unexplained colorectal adenomatous polyposis. Familial Cancer. 15(2). 281–288. 40 indexed citations
16.
Uhlig, Holm H., Antje Körner, Jürgen Kratzsch, et al.. (2013). Sirolimus treatment of severe PTEN hamartoma tumor syndrome: case report and in vitro studies. Pediatric Research. 75(4). 527–534. 46 indexed citations
17.
Laner, Andreas, et al.. (2010). Clopidogrel and proton pump inhibitor (PPI) interaction: separate intake and a non-omeprazole PPI the solution?. European journal of medical research. 15(5). 220–220. 20 indexed citations
19.
Morak, Monika, et al.. (2008). Report on de-novo mutation in the MSH2 gene as a rare event in hereditary nonpolyposis colorectal cancer. European Journal of Gastroenterology & Hepatology. 20(11). 1101–1105. 10 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026